Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2009-7-17
pubmed:abstractText
Hypoxia-inducible factor-1 (HIF-1) is the key regulator of cellular responses to hypoxia and presumably plays a central role in the control of tumor growth. Polymorphisms or mutations increasing its activity and stability in vitro under normoxia have recently been identified. In this study, we aimed to investigate the effect of C1772T and G1790A single nucleotide polymorphisms (SNPs), located within the exon 12 of HIF-1alpha on the prognosis of early stages of oral squamous cell carcinoma (OSCC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1534-4681
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2351-8
pubmed:meshHeading
pubmed-meshheading:19449077-Adolescent, pubmed-meshheading:19449077-Adult, pubmed-meshheading:19449077-Aged, pubmed-meshheading:19449077-Aged, 80 and over, pubmed-meshheading:19449077-Carcinoma, Squamous Cell, pubmed-meshheading:19449077-Case-Control Studies, pubmed-meshheading:19449077-Female, pubmed-meshheading:19449077-Genotype, pubmed-meshheading:19449077-Humans, pubmed-meshheading:19449077-Hypoxia-Inducible Factor 1, alpha Subunit, pubmed-meshheading:19449077-Lymphatic Metastasis, pubmed-meshheading:19449077-Male, pubmed-meshheading:19449077-Middle Aged, pubmed-meshheading:19449077-Mouth Neoplasms, pubmed-meshheading:19449077-Neoplasm Staging, pubmed-meshheading:19449077-Polymerase Chain Reaction, pubmed-meshheading:19449077-Polymorphism, Restriction Fragment Length, pubmed-meshheading:19449077-Polymorphism, Single Nucleotide, pubmed-meshheading:19449077-Prognosis, pubmed-meshheading:19449077-Survival Rate, pubmed-meshheading:19449077-Young Adult
pubmed:year
2009
pubmed:articleTitle
Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.
pubmed:affiliation
Department of Oral & Maxillofacial Surgery, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain. maxmferm@excite.com
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't